B. Zethelius

552 total citations
14 papers, 395 citations indexed

About

B. Zethelius is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, B. Zethelius has authored 14 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in B. Zethelius's work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Diabetes Treatment and Management (3 papers) and Diabetes Management and Research (3 papers). B. Zethelius is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Diabetes Treatment and Management (3 papers) and Diabetes Management and Research (3 papers). B. Zethelius collaborates with scholars based in Sweden, United Kingdom and Denmark. B. Zethelius's co-authors include Björn Eliasson, Jan Cederholm, Soffia Guðbjörnsdóttir, Katarina Eeg‐Olofsson, Lena Kilander, Lars Lannfelt, Peter M. Nilsson, Elina Rönnemaa, Johan Sundström and Liisa Byberg and has published in prestigious journals such as Neurology, Diabetologia and European Urology.

In The Last Decade

B. Zethelius

13 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Zethelius Sweden 11 142 116 96 69 69 14 395
Satoshi Iimuro Japan 12 196 1.4× 163 1.4× 99 1.0× 86 1.2× 40 0.6× 31 542
Cédric Gaxatte France 10 91 0.6× 66 0.6× 64 0.7× 41 0.6× 56 0.8× 25 485
Darryl Meeking United Kingdom 10 124 0.9× 156 1.3× 63 0.7× 65 0.9× 62 0.9× 32 453
Tetsutaro Matayoshi Japan 12 104 0.7× 192 1.7× 48 0.5× 49 0.7× 83 1.2× 25 403
Elli Stefanadi Greece 13 142 1.0× 232 2.0× 93 1.0× 87 1.3× 79 1.1× 17 567
Martin Kammerl Germany 17 155 1.1× 226 1.9× 83 0.9× 114 1.7× 132 1.9× 33 706
György Ábrahám Hungary 12 102 0.7× 234 2.0× 67 0.7× 63 0.9× 67 1.0× 37 450
Eita Kumagai Japan 12 124 0.9× 133 1.1× 56 0.6× 64 0.9× 70 1.0× 28 393
E. Podjarny Israel 14 71 0.5× 115 1.0× 106 1.1× 59 0.9× 71 1.0× 48 707
Fernando Grover‐Páez Mexico 9 88 0.6× 115 1.0× 35 0.4× 40 0.6× 94 1.4× 26 386

Countries citing papers authored by B. Zethelius

Since Specialization
Citations

This map shows the geographic impact of B. Zethelius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Zethelius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Zethelius more than expected).

Fields of papers citing papers by B. Zethelius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Zethelius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Zethelius. The network helps show where B. Zethelius may publish in the future.

Co-authorship network of co-authors of B. Zethelius

This figure shows the co-authorship network connecting the top 25 collaborators of B. Zethelius. A scholar is included among the top collaborators of B. Zethelius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Zethelius. B. Zethelius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Garmo, Hans, Mieke Van Hemelrijck, Jan Adolfsson, et al.. (2021). Diabetes control in men with type 2 diabetes mellitus and prostate cancer treated with GnRH Agonists: A nationwide, population-based cohort study. European Urology. 79. S1188–S1188.
2.
Zethelius, B., Soffia Guðbjörnsdóttir, Björn Eliasson, Katarina Eeg‐Olofsson, & Jan Cederholm. (2013). Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register. European Journal of Preventive Cardiology. 21(2). 244–251. 46 indexed citations
3.
Eliasson, Björn, Soffia Guðbjörnsdóttir, B. Zethelius, Katarina Eeg‐Olofsson, & Jan Cederholm. (2013). LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes. European Journal of Preventive Cardiology. 21(11). 1420–1428. 47 indexed citations
4.
Rönnemaa, Elina, B. Zethelius, B. Vessby, et al.. (2012). Serum fatty-acid composition and the risk of Alzheimer’s disease: a longitudinal population-based study. European Journal of Clinical Nutrition. 66(8). 885–890. 40 indexed citations
5.
Ekström, Nils, Mervete Miftaraj, Åke Svensson, et al.. (2012). Glucose‐lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register. Diabetes Obesity and Metabolism. 14(8). 717–726. 28 indexed citations
6.
Nilsson, Peter M., Jan Cederholm, B. Zethelius, et al.. (2011). Trends in blood pressure control in patients with type 2 diabetes – Data from the Swedish National Diabetes Register (NDR). Blood Pressure. 20(6). 348–354. 40 indexed citations
7.
8.
Grundmark, Birgitta, B. Zethelius, Hans Garmo, & Lars Holmberg. (2011). Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up. BMC Cancer. 11(1). 431–431. 19 indexed citations
9.
Nilsson, Peter M., Jan Cederholm, Katarina Eeg‐Olofsson, et al.. (2009). Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR). Diabetes & Metabolism. 35(6). 439–446. 35 indexed citations
10.
Nathanson, David, B. Zethelius, Christian Berne, et al.. (2009). Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease. Diabetologia. 53(2). 277–280. 18 indexed citations
11.
Nilsson, Peter M., Jan Cederholm, Björn Eliasson, et al.. (2008). Successful long-term blood pressure control and lower incidence of cardiovascular disease: A report from the Swedish National Diabetes Register (NDR). Journal of Hypertension. 26. 202–202. 1 indexed citations
12.
Sundelöf, Johan, Erik Ingelsson, Johan Sundström, et al.. (2008). Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology. 71(14). 1072–1079. 81 indexed citations
13.
14.
Lithell, Hans, Johan Sundström, Johan Ärnlöv, et al.. (2000). Epidemiological and Clinical Studies on Insulin Resistance and Diabetes. Upsala Journal of Medical Sciences. 105(2). 135–150. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoshi Iimuro Breakdown of academic impact, for papers by Cédric Gaxatte Breakdown of academic impact, for papers by Darryl Meeking Breakdown of academic impact, for papers by Tetsutaro Matayoshi Breakdown of academic impact, for papers by Elli Stefanadi Breakdown of academic impact, for papers by Martin Kammerl Breakdown of academic impact, for papers by György Ábrahám Breakdown of academic impact, for papers by Eita Kumagai Breakdown of academic impact, for papers by E. Podjarny Breakdown of academic impact, for papers by Fernando Grover‐Páez
Rankless by CCL
2026